The Impressive TimesNew Delhi, April 3, 2024: Hindustan Syringes and Medical Devices (HMD), one of the leading manufacturer of Disposable Syringes in the World and possibly the largest for Auto Disable syringes, haslaunched the most innovative and first-of-its kind Dispojektsafety needle syringes. With the revolutionary Dispojektsafety needle syringes, HMD aims to reduce prevalence of accidental Needle Stick Injuries (NSIs) among health workers, reduction of infection control cost, reduce cost of disposal and training- offering long term financial impact for the healthcare sector.
“Equipped with a safety shield, Dispojekt syringe addresses critical concerns of needle stick injuries and reaffirms our commitment as market leader towards excellence in healthcare. It is a great outcome of our Make in India resolve as envisioned by Prime Minister Narendra Modi to realize the goal of Viksit Bharat,” said MrRajiv Nath, Managing Director, HMD.
There is significant headroom for innovation and growth in medical devices industry and the future of healthcare technology rests on robust R&D. With the disposable syringe market size in India estimated to be 4-5 billion per year and needle 5-6 billion, and 80 % of which in the hands of private sector players.“We aim for 60-70 % market share in the next three years, thanks to our innovative Dispojekt”, informed MrNath.
“HMD believes in delivering the best at the most competitive costing. Dispojekt safety needle syringesare going to be the game changer in our fight against NSIs. We are aiming to produce 200 million syringes and needles per annum for which we have invested approximately Rs 70 cr in its first phase,” revealed MrNath.
“In the second phase, we will increase the capacity to 300 million pieces per annum by investing another Rs 10 crore to Rs 15 crore,” added MrNath, sounding buoyant over expected return on investment over the next five years as HMD is a debt-free financially strong AAA rated manufacturer and the target has been financed from internal accounts.
As one of the most reputed medical device manufacturers with state-of-the-art manufacturing facility in Faridabad, Haryana, HMD produces over three billion injection needles per annum, catering to the needs of its primary markets comprising India, Europe, US, Middle East, and its secondary markets of South-East Asia and Africa.
Talking about managing inventory and distribution of Dispojektsafety needle syringes, MrSohailNath, Executive Director of the company, said that HMD has a national distribution network of over 5000 dealers and has over 50 contractual stock points in key metropolitan, Tier I and Tier II cities, ensuring that supply chain management is uninterrupted as has been the case for its DispoVan brand syringes with rapid short term quick delivery cycle.
Reflecting further, he said that Dispojektsafety needle syringeswill not only further strengthen our position as market leader but will give a boost to our collective efforts to check NSIs leading to Hepatitis B, C and HIV among healthcare personnel, betting on its quality, uniqueness and affordability.
“Dispojektsafety needle syringes have been designed to be affordable for the developing world including India and is nearly half the cost of single use syringe used in the USA and Europe where 100 per cent use is mandatory by legislation,” said MrSohail.
As per a publication in International Journal of Community Medicine and Public Health, the overall prevalence of NSIs in India in 2021 was 20.1 %. It has been observed that NSIs prevalence among nurses was 31.3 %, technicians 37.5 %, ward boys and other staff 15 %, and sweepers of public and private hospitals 15.6 %.
According to a research, the prevalence of NSIs among healthcare workers in India is between 57% and 73%. In fact, approximately 54% of NSIs are reported because of using hypodermic needle. Many instances of NSIs go unreported, making it a way more serious problem than it appears. To shield frontline healthcare workers from the dangers of NSIs, we at HMD have pioneered a new safety needle for injections –Dispojekt Needles.
The Center for Disease Control and Prevention, US, has estimated that only 10 % of NSIs injuries are reported. In developing countries, which have the highest global prevalence of HIV, the prevalence of needle stick injuries is also at the highest level. Studies report an annual of 100,000 injuries caused by sharp objects among nurses in the UK as well.
Asked about clinical studies conducted to affirm safety and efficacy of Dispojektsafety needle syringes, MrSohail said, “Dispojekt syringes are a part of Safety Engineered Devices (SED). Numerous clinical studies and evaluations have been conducted to assess the safety and efficacy of syringes with safety needles. There are clinical trials which have proved that the use of SED has reduced the incidence of needle stick injuries in healthcare workers.”
“One such publication in the European Journal of Microbiology and Immunology, a German study confirms that the uses of SED have reduced NSIs by 17.6 %. Another study published in the British Journal of Nursing in 2020 confirms the above fact that SED reduces NSI. It’s important to note that research in the medical field is ongoing, and new studies may have been conducted yet to get published or under review,” he said.
According to the World Health Report 2002, out of 35 million healthcare workers, two million of them experience percutaneous exposure to infectious diseases each year. It further notes that 37.6 % of Hepatitis B, 39 % of Hepatitis C, and 4.4 % of Human Immunodeficiency Virus (HIV)/AIDS among healthcare workers (HCWs) around the world are due to NSIs. Do we have latest data
The launch of Dispojektsafety needle syringes, an innovative and cost-effective product from the R&D lab of the world’s largest manufacturer of Auto-Disable (AD) syringes, assumes significance in view of the monstrous magnitude of NSIs among the health workers.
No Comments: